Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Yossix, First Half Ordinary Profit Increases by 15%, Jul-Sep Ordinary Profit Increases by 30%
3221 Yossix Holdings Co., Ltd. 【J-GAAP】
Earnings ReportYossix Holdings Co., Ltd. <3221> [TSE Prime] announced its financial results after the market closed on November 7th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) increased 14.6% from the same period last year, reaching 1.61 billion yen. Progress toward the full-year plan of 2.65 billion yen was 60.6%, also surpassing the five-year average of 41.1%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease 9.1% from the same period last year to 1.04 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew 29.9% from the same period last year, reaching 0.98 billion yen. The operating profit margin rose from 11.7% in the same period last year to 13.4%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 10,264 | 1,082 | 1,220 | 804 | 77.8 | 48.1 | Nov 10, 2023 | J-GAAP |
| Apr - Sep, 2024 | 11,252 | 1,261 | 1,406 | 931 | 91.3 | 55.0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 | 12,441 | 1,417 | 1,611 | 1,035 | 101.2 | 60.6 | Nov 7, 2025 | J-GAAP |
| YoY | +10.6% | +12.4% | +14.6% | +11.2% | +10.8% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 14 | May 9, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 12,441 | 1,417 | 1,611 | 1,035 | 101.2 | 14 | Nov 7, 2025 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 11,653 | 1,067 | 1,152 | 827 | 81.0 | 14 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 11,743 | 987 | 1,047 | 785 | 76.5 | 14 | Nov 7, 2025 | J-GAAP |
| YoY | +0.8% | -7.5% | -9.1% | -5.1% | -5.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 21,117 | 2,322 | 2,538 | 1,809 | 175.1 | 26 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 22,905 | 2,328 | 2,558 | 1,758 | 172.2 | 28 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 24,184 | 2,404 | 2,658 | 1,820 | 177.5 | 28 | May 9, 2025 | J-GAAP |
| YoY | +5.6% | +3.3% | +3.9% | +3.5% | +3.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 5,691 | 668 | 758 | 503 | 49.3 | 11.7 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 5,898 | 635 | 675 | 491 | 48.1 | 10.8 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 5,755 | 432 | 477 | 336 | 32.9 | 7.5 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 6,007 | 555 | 626 | 396 | 38.8 | 9.2 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 6,434 | 862 | 985 | 639 | 62.5 | 13.4 | Nov 7, 2025 | J-GAAP |
| YoY | +13.1% | +29.0% | +29.9% | +27.0% | +26.6% |
Related Articles
Toyo Gosei, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 13%
COSMO BIO, Jan-Sep (Cumulative 3Q) Ordinary Profit Decreases by 4%, Jul-Sep Ordinary Profit Decreases by 45%
IPS, Jul-Sep (1Q) Ordinary Profit Increases by 2.3 times
Shimadzu, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 24%, Dividend Revised Upward by 1 Yen
LINKBAL, Returning to Profitability This Year
Monogatari, Jul-Sep (1Q) Ordinary Profit Increases by 22%
IPS, First Half Ordinary Profit Increases by 46%
SEIKO, First Half Ordinary Profit Increases by 17%, Jul-Sep Ordinary Profit Increases by 14%
Oncolys BioPharma, Jul-Sep (3Q) Net Income Loss Narrows
OOTOYA Holdings, First Half Ordinary Profit Increases by 14%, Jul-Sep Ordinary Profit Increases by 11%